Zhong introduces convalescence plasma trial in COVID-19 treatment

chinadaily.com.cn | Updated: 2020-03-30 11:49

In a video consultation with US medical experts on Friday, Zhong Nanshan, a prominent Chinese respiratory disease expert, introduced convalescence plasma trial in treating the COVID-19 in China.

Please feel free to contact us by sending your questions to question@chinadaily.com.cn or commenting on China Daily app. We will ask experts to answer them.

Editor's picks

TCM COVID-19 treatment receives market approval in Canada

Volunteer village clinics help with COVID wave

Young people get healthy to ward off infections

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349